Morgan Stanley IM: Momentum Ruled In 2024, But Reversal Likely In 2025

Morgan Stanley IM: Momentum Ruled In 2024, But Reversal Likely In 2025
Märkte

2024 has experienced one of the top momentum runs of the past thirty years. Historically, such strong performance has led to a near-full reversal in performance in the subsequent year. Cyril Moulle-Berteaux explains.

03.01.2025 | 05:13 Uhr

Bottom Line

2024 has experienced one of the top momentum runs of the past thirty years. Historically, such strong performance has led to a near-full reversal in performance in the subsequent year, though the middling valuations of momentum stocks temper that conclusion somewhat. Odds are still 2-1 against momentum stocks for 2025.

Thus far in 2024, momentum has ruled more than any other factor. Sure, high growth and high quality stocks have outperformed low growth and junkier stocks, but high momentum stocks have exploded higher (relative to low momentum stocks). The current momentum run is one of the top momentum runs since 1995 (see Display 1), with high momentum stocks outperforming low momentum by +28% year-on-year as of Dec 11th, a two standard-deviation event.

We define momentum as the quintile of stocks with the highest 12-month risk-adjusted returns vs. the quintile with the lowest returns.1 So what does the current crop of high momentum stocks look like?

  • It is a surprisingly well-diversified bunch of stocks with absolute performance of 36% over the past year, and with the highest weight in Broad Tech (27% of the basket) and Financials (24%, of which almost half are regional banks). Industrials and Healthcare are also well-represented (13% and 11%, respectively) though there are few Energy, Materials, and Consumer stocks (13% of the basket combined).
  • High momentum stocks today are a marginally more expensive (18x) than the average stock (17x) but also have higher margins and a higher forecasted EPS growth rate.

Extreme performance (top decile), as we have seen in the past year, historically bodes poorly for future performance of high momentum stocks, most decisively if one looks out 6-12 months.

  • “Top decile” performance for momentum is anything above +19% in one year. Once this has been reached (as it was in June 2024), the run typically continues for another 6 months. From start to finish, a top decile momentum run historically sees +35% performance over eleven months, then reverses almost fully (down -25%) in the subsequent 10 months (see Display 2). By comparison, the current momentum run has seen +28% performance over 12 months. If history is any guide, we would expect a substantial reversal in 2025.
  • One moderating factor: high momentum stocks are only modestly expensive vs. low momentum stocks (58th percentile of history) which, on its own, would point to average future performance. However, combined with the extreme performance of the past year, the odds are still 2 to 1 for a momentum reversal.


Bottom line: 2024 has experienced one of the top momentum runs of the past thirty years. Historically, such strong performance has led to a near-full reversal in performance in the subsequent year, though the middling valuations of momentum stocks temper that conclusion somewhat. Odds are still 2-1 against momentum stocks for 2025.

1 50/50 equal & cap-weighted, and beta-adjusted. Momentum defined as 12m beta-adjusted return of each stock excluding the past month’s performance because high one-month returns are known to experience a subsequent one-month reversal.


IMPORTANT DISCLOSURES

The views and opinions and/or analysis expressed are those of the author or the investment team as of the date of preparation of this material and are subject to change at any time without notice due to market or economic conditions and may not necessarily come to pass. Furthermore, the views will not be updated or otherwise revised to reflect information that subsequently becomes available or circumstances existing, or changes occurring, after the date of publication. The views expressed do not reflect the opinions of all investment personnel at Morgan Stanley Investment Management (MSIM) and its subsidiaries and affiliates (collectively “the Firm”), and may not be reflected in all the strategies and products that the Firm offers.

Forecasts and/or estimates provided herein are subject to change and may not actually come to pass. Information regarding expected market returns and market outlooks is based on the research, analysis and opinions of the authors or the investment team. These conclusions are speculative in nature, may not come to pass and are not intended to predict the future performance of any specific strategy or product the Firm offers. Future results may differ significantly depending on factors such as changes in securities or financial markets or general economic conditions.

This material has been prepared on the basis of publicly available information, internally developed data and other third-party sources believed to be reliable. However, no assurances are provided regarding the reliability of such information and the Firm has not sought to independently verify information taken from public and third-party sources.

This material is a general communication, which is not impartial and all information provided has been prepared solely for informational and educational purposes and does not constitute an offer or a recommendation to buy or sell any particular security or to adopt any specific investment strategy. The information herein has not been based on a consideration of any individual investor circumstances and is not investment advice, nor should it be construed in any way as tax, accounting, legal or regulatory advice. To that end, investors should seek independent legal and financial advice, including advice as to tax consequences, before making any investment decision.

The indexes are unmanaged and do not include any expenses, fees or sales charges. It is not possible to invest directly in an index. Any index referred to herein is the intellectual property (including registered trademarks) of the applicable licensor. Any product based on an index is in no way sponsored, endorsed, sold or promoted by the applicable licensor and it shall not have any liability with respect thereto. The S&P 500® Index measures performance of the large cap segment of the U.S. equities market, covering approximately 75% of the U.S. market, including 500 leading companies in the U.S. economy.

Diesen Beitrag teilen: